Haloperidol administration to rats during pregnancy induces permanent alterations in serum lipoprotein patterns of progeny.
The rat is notoriously resistant to vascular disease, but administration of haloperidol prenatally to the pregnant dam results in hyperlipidemic changes in F1 and F2 progeny. Total serum cholesterol concentrations in the F1 males reach levels three or more times greater than controls by one year of age. The phenomenon indicates a link between dopaminergic elements of the autonomic nervous system and cholesterol metabolism, a phenomenon heretofore unrecognized. Transfer of the hypercholesterolemia into the second generation further suggests that haloperidol induces a permanent change in the genetic control of lipoprotein metabolism. Although the observations are preliminary, they warrant consideration when administering the drug to pregnant women.
Van Gent
C M
CM
Loma Linda University, California.
Sandberg
L B
LB
Boucek
R J
RJ
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D001921:Brain / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D005260:Female; D006220:Haloperidol / Q000633:toxicity*; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000187:drug effects
D008074:Lipoproteins; D011954:Receptors, Dopamine; D002784:Cholesterol; D006220:Haloperidol